Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now     
Drug Delivery Technologies that Deliver Solutions to You

Drug Delivery Technologies that Deliver Solutions to You

Taiwan Liposome Company (TLC)

TLC has a complete portfolio of lipid-based technologies with broad application coverage from small to large molecule drugs. It utilizes five proprietary technologies to develop therapies for oncologic and ophthalmologic diseases and treatments for the management of acute and chronic pain.
Taiwan Liposome Company (TLC)

Taho Pharmaceuticals

Taho Pharmaceuticals focuses on applying its proprietary drug delivery technologies to improve delivery of existing drug compounds for the treatment of cancer and central nervous system (CNS) conditions. Its Transepithelial Delivery Systems (TDS) can turn oral and injectable drugs to transdermal patches and oral thin films to address challenges encountered in oral drug delivery.
Taho Pharmaceuticals

Innopharmax

Innohparmax's proprietary OralPAS® technology is a self-microemulsifying drug delivery system (SMEDDS) that allows drugs previously unsuited for oral administration to be encased in nano-scale microemulsions for increased effectiveness in oral use. This technology increases the solubility and dissolution of the drug, protects drugs against enzyme degradation in the GI tract, and enhances drug absorption through structural or fluidity changes in the intestinal membrane.
Innopharmax

Orient Pharma

Orient Pharma's Multiple-Phasic Release Technology (MPRT) delivers drug compounds through transdermal patches and oral medications to provide improved therapeutic effects. MPRT reduces the risk of local irritation and toxicity, offers predictable bioavailability, reduces the likelihood of dose dumping, and minimizes fluctuations in plasma concentration of drug.
Orient Pharma

Intech Biopharm

Intech Biopharm specializes in new dosage, new combination, new delivery, and high barrier generic drug development and manufacturing with a focus on respiratory diseases. It is the the only company in Taiwan that provides and manufactures high-barrier obstructive airway disease drugs as enabled by the low-alcohol formulation (iLEF) platform.
Intech Biopharm

SynCore Biotechnology

SynCore Biotechnology focuses on the development of oncology and ophthalmology new drugs. Its EndoTAGTM technology targes vascular endothelial cells in the regenerated blood vessels that carry negative electric charges within the tumor, and destroys cancerous cells through anti-angiogenesis.
SynCore Biotechnology

Foresee Pharmaceuticals

Foresee Pharmaceuticals' stabilized injectable formulation (SIF) is a sustained-release drug delivery platform that enables the development of tailor-made controlled release drug delivery of small molecules, peptides, and proteins. This technology enables long-acting dosage formulations and is widely applicable to various chronic diseases.
Foresee Pharmaceuticals

MegaPro Biomedical

MegaPro Biomedical focuses on the development of nanomedicine. Its PEGylated iron oxide nanoparticle technology can be used as a new magnetic resonance imaging (MRI) contrast agent and non-sugar-based intravenous (IV) iron for treating iron deficiency anemia with less side effects and higher potency.
MegaPro Biomedical
More Topics
  • Taiwan's Cutting-edge and Innovative Surgical Technology
  • Clinical Applications of Digital Technology in Taiwan
  • 2017 BioTaiwan Highlights
  • The Critical Step for Child Development in Neonatal Problems: Early Screening Diagnosis, and Intervention
  • Cardiovascular Disease & Stroke Treatment
  • From Plants to Botanical Drugs
  • TAIWAN EXPO 2017 di Indonesia Taiwan Healthcare+ Featured Companies
  • Taiwan Healthcare+ connects you with the best API partners
  • Taiwan Healthcare+ connects you with SMART healthcare solutions
  • Assisted Reproductive Technology
  • Integrating ICT and Precision Machinery with Medicine
  • Taiwan's Biomedical Enterprises to Reach New Breakthroughs in Export